{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:38:24Z","timestamp":1781714304623,"version":"3.54.5"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Bloodstream infections are a critical challenge worldwide due to the slow turnaround time of conventional microbiological tests for detecting bacteremia in septic patients. Noscendo GmbH (Duisburg, Germany) has developed the CE\/IVD pipeline DISQVER for clinical metagenomics testing based on cell-free DNA (cfDNA) from blood samples to address this issue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective study to evaluate the diagnostic utility of this methodological setup in improving treatment decisions since it was introduced into our clinical setting. Between January 2021 and June 2022, the first 300 cases in which DISQVER was applied at our university hospital were collected and analyzed. The results were compared with routine microbiology test results, clinical picture, associated treatment decisions, and clinical course.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings demonstrate that DISQVER results where no pathogen was reported effectively ruled out bacterial bloodstream infections, whereas positive results varied in their usefulness. While the metagenomic approach proved highly valuable for detecting non-culturable and rare pathogens, its utility was limited in cases where detected microorganisms were commonly associated with the microbiota.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Performing on-site analysis might mitigate delays resulting from logistical challenges and might help optimizing antibiotic stewardship. Once prompt results can be obtained, the relevance of incorporating molecular resistograms will become more pronounced. Further, the specific patient subgroups that most benefit from this analysis must be worked out. Guiding clinicians in identifying the infection focus based on the detected bacteria would significantly improve patient care. Lastly, evidence of filamentous fungi must be diligently followed up.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1504262","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T06:25:15Z","timestamp":1738218315000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Retrospective analysis of 300 microbial cell-free DNA sequencing results in routine blood stream infection diagnostics"],"prefix":"10.3389","volume":"15","author":[{"given":"Claudio","family":"Neidh\u00f6fer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Y\u00fcr\u00fckt\u00fcmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Hattenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Mispelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias A. W.","family":"Holderried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijo","family":"Par\u010dina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.7754\/Clin.Lab.2016.160615","article-title":"Cell free DNA and procalcitonin as early markers of complications in ICU patients with multiple trauma and major surgery","volume":"62","author":"Ahmed","year":"2016","journal-title":"Clin. Lab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jinf.2021.03.003","article-title":"Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock","volume":"82","author":"Asner","year":"2021","journal-title":"J. Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1186\/s13063-021-05667-x","article-title":"Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)\u2014study protocol for a randomized, controlled, interventional, open-label, multicenter trial","volume":"22","author":"Brenner","year":"2021","journal-title":"Trials"},{"key":"B5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41390-021-01878-9","article-title":"Antibiotics in critically ill children\u2014a narrative review on different aspects of a rational approach","volume":"91","author":"Bruns","year":"2022","journal-title":"Pediatr. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3947\/ic.2014.46.1.1","article-title":"Biomarkers of sepsis","volume":"46","author":"Cho","year":"2014","journal-title":"Infect. Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1364-8535-17-1001","article-title":"Unrevealing culture-negative severe sepsis","volume":"17","author":"de Prost","year":"2013","journal-title":"Crit. Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc11466","article-title":"Prognostic utility and characterization of cell-free DNA in patients with severe sepsis","volume":"16","author":"Dwivedi","year":"2012","journal-title":"Crit. Care"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e87741","DOI":"10.1371\/journal.pone.0087741","article-title":"High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment","volume":"9","author":"Forsblom","year":"2014","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/jof7020127","article-title":"The evolving landscape of fungal diagnostics, current and emerging microbiological approaches","volume":"7","author":"Freeman Weiss","year":"2021","journal-title":"J. Fungi."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1093\/jpids\/piaa170.024","article-title":"75: microbial cell-free DNA sequencing for prediction of culture-negative infection events in children with cancer","volume":"10","author":"Goggin","year":"2021","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jmoldx.2019.12.006","article-title":"Rapid next-generation sequencing\u2013based diagnostics of bacteremia in septic patients","volume":"22","author":"Grumaz","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-016-0326-8","article-title":"Next-generation sequencing diagnostics of bacteremia in septic patients","volume":"8","author":"Grumaz","year":"2016","journal-title":"Genome Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-pathmechdis-012418-012751","article-title":"Clinical metagenomic next-generation sequencing for pathogen detection","volume":"14","author":"Gu","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/CMR.00062-05","article-title":"Updated review of blood culture contamination","volume":"19","author":"Hall","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.7150\/thno.45554","article-title":"Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing","volume":"10","author":"Han","year":"2020","journal-title":"Theranostics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2018.06.009","article-title":"Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease","volume":"92","author":"Hong","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2024.06.005","article-title":"Cell-free DNA: a promising biomarker in infectious diseases","volume":"11","author":"Hu","year":"2024","journal-title":"Trends Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3760\/cma.j.issn.2095-4352.2018.010.003","article-title":"Predictive value of plasma cell-free DNA for prognosis of sepsis","volume":"30","author":"Huang","year":"2018","journal-title":"Zhonghua. Wei. Zhong. Bing. Ji. Jiu. Yi. Xue."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e02530","DOI":"10.1128\/spectrum.02530-22","article-title":"Diagnosis of neurological infections in pediatric patients from cell-free DNA specimens by using metagenomic next-generation sequencing","volume":"11","author":"Li","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1556\/EuJMI.4.2014.1.1","article-title":"Molecular diagnosis of sepsis: New aspects and recent developments","volume":"4","author":"Liesenfeld","year":"2014","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/1469-0691.12101","article-title":"Long-term mortality following bloodstream infection","volume":"19","author":"Lillie","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"B25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.arcmed.2016.08.004","article-title":"Diagnosis of sepsis with cell-free DNA by next-generation sequencing technology in ICU patients","volume":"47","author":"Long","year":"2016","journal-title":"Arch. Med. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10096-014-2153-4","article-title":"Developments for improved diagnosis of bacterial bloodstream infections","volume":"33","author":"Loonen","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2018.03.005","article-title":"Long-term morbidity and mortality following bloodstream infection: a systematic literature review","volume":"77","author":"McNamara","year":"2018","journal-title":"J. Infect."},{"key":"B28","first-page":"ofae328","article-title":"Plasma microbial cell-free DNA next-generation sequencing can be a useful diagnostic tool in patients with osteoarticular infections","volume-title":"Open Forum Infectious Diseases","author":"Petri","year":"2024"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e13778","DOI":"10.1111\/tid.13778","article-title":"Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression","volume":"24","author":"Redondo","year":"2022","journal-title":"Transplant. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1128\/AAC.00462-11","article-title":"Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis","volume":"56","author":"Retamar","year":"2012","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B31","first-page":"ofaa298","article-title":"Barriers to adherence to antimicrobial stewardship postprescription review and feedback for broad-spectrum antimicrobial agents: a nested case-control study","volume-title":"Open forum infectious diseases","author":"Takamatsu","year":"2020"},{"key":"B32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00134-020-05950-6","article-title":"Bloodstream infections in critically ill patients: an expert statement","volume":"46","author":"Timsit","year":"2020","journal-title":"Intensive Care Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","article-title":"Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies","volume":"14","author":"Volik","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.659390","article-title":"Plasma microbial cell-free DNA sequencing technology for the diagnosis of sepsis in the ICU","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B35","article-title":"New Biomarkers for Sepsis. Sepsis - An Ongoing and Significant Challenge","author":"Xie","year":"2012"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.951703","article-title":"Metagenomic next-generation sequencing of cell-free and whole-cell DNA in diagnosing central nervous system infections","volume":"12","author":"Yu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1504262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T06:25:18Z","timestamp":1738218318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1504262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":36,"alternative-id":["10.3389\/fcimb.2025.1504262"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1504262","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"article-number":"1504262"}}